Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CollPlant Biotechnologies Ltd. - Ordinary Shares
(NQ:
CLGN
)
2.400
+0.080 (+3.45%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Oct 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CollPlant Biotechnologies Ltd. - Ordinary Shares
< Previous
1
2
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 21, 2025
Via
Benzinga
Analyst Expectations For CollPlant Biotechnologies's Future
August 21, 2025
Via
Benzinga
CollPlant Biotechnologies Ltd (NASDAQ:CLGN) Q2 2025 Earnings Fall Significantly Short of Estimates
August 20, 2025
CollPlant (CLGN) Q2 2025 results miss analyst estimates, with revenue of $180K far below expectations. Shares fell in pre-market trading on the earnings disappointment.
Via
Chartmill
Earnings Scheduled For August 20, 2025
August 20, 2025
Via
Benzinga
What's Next: CollPlant Biotechnologies's Earnings Preview
August 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
June 09, 2025
Via
Benzinga
Dow Edges Higher; Dell Shares Fall After Q1 Results
May 30, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Friday's Intraday Session
May 30, 2025
Via
Benzinga
Nasdaq Down 100 Points; Chicago PMI Dips In May
May 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 30, 2025
Via
Benzinga
Earnings Preview: CollPlant Biotechnologies
May 27, 2025
Via
Benzinga
CollPlant Biotechnologies's Earnings: A Preview
November 26, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
August 21, 2024
Via
Benzinga
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
May 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 28, 2025
Via
Benzinga
Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday
May 28, 2025
Via
Benzinga
Recap: CollPlant Biotechnologies Q3 Earnings
November 29, 2023
Via
Benzinga
Earnings Outlook For CollPlant Biotechnologies
November 28, 2023
Via
Benzinga
Earnings Scheduled For May 28, 2025
May 28, 2025
Via
Benzinga
Earnings Scheduled For March 26, 2025
March 26, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 27, 2024
Via
Benzinga
Earnings Scheduled For November 27, 2024
November 27, 2024
Via
Benzinga
CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024
August 20, 2024
CLGN stock results show that CollPlant Biotechnologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024
May 29, 2024
CLGN stock results show that CollPlant Biotechnologies met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023
April 04, 2024
CLGN stock results show that CollPlant Biotechnologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For April 4, 2024
April 04, 2024
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion.
Via
Benzinga
Earnings Scheduled For November 29, 2023
November 29, 2023
Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 19, 2023
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Starting at $3.75
/
week.
Subscribe Today